Liver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related il...

India's pharma market took a dip in March after poor sales of respiratory and anti-infective therapies dropped post-winter. April saw the m...

India's pharmaceutical market witnessed a robust 9% month-on-month growth in February, driven by strong performance in cardiology and anti-...

Russia's invasion of Ukraine in February saw them and allies Belarus become outcasts of world sport. Russia were kicked out of the football...

For the first time ever the film festival has invited major OTT players to participate.

Purifying Neem Face Wash has emerged as Himalaya Drug Company’s new money-spinner, outstripping its herbal liver medicine, Liv.52.

The company that sells medicinal products, including the popular liver protective brand Liv.52, had posted revenues of Rs 1,300 crore in th...

Healthcare products-maker Himalaya Drug Company will add 100 sales persons to its 200-strong workforce in the state.

Writing the verdict for the bench, Justice Singh granted six months to SBL Ltd to "liquidate" existing stock of Liv-T.

Its pharma head is a rock guitarist, its big boss doesn't chase short-term returns and a pill it launched in the 1950s is still a bestselle...

Drugs launched over 20 yrs ago remain money-spinners in the Indian pharma mkt because of strong brand recall and better access in smaller c...

They are some of the most common drugs consumed in India. But PM’s high-level expert group on universal health coverage claims that they ar...

Our personal care portfolio is present in around 40 nations. We also have 50 stand-alone outlets across South Africa, Malaysia, S’pore and ...

Herbal drugs and personal care product maker Himalaya Healthcare plans to cultivate endangered plants to develop new drugs, a company execu...

Pharma companies have recorded robust sales in May 2009, as per ORG IMS data, with a moving annual total (MAT) of 10.4% at Rs 36,048 crore ...

Cipla's sales grew 15.3% from last month, garnering 4.92% while Ranbaxy sales grew just 0.9% with a mkt share of 4.81%. Drug cos in price w...

For a sales index that’s perpetually skewed towards cough syrups, which is often misused as a cheap substitute for alcohol, and pain killer...